sar425899 sanofi glp-1 glucagon dual agonist Role of a Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor (Twincretin) in Glycemic Control: From Pathophysiology to Treatment Role of a Dual Glucose-Dependent

[DOI] [PubMed] [Google Scholar] 25.Matthews J.E., Stewart M.W., De Boever E.H., Dobbins R.L., Hodge R.J., Walker S.E

Back Brandt, SJ, Mller, TD, DiMarchi, RD, et al (12 Sept 2018) 'Peptide-based multi-agonists: a new paradigm in metabolic pharmacology', Journal of Internal Medicine

They are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind

Be sure to let your clinician know about all medications youre taking

This helps you know about the risks and what might work best for you

Sikirica M, Martin A, Wood R, et al